Safety, Tolerability, and Efficacy of AXA1125 in NASH With Fibrosis

Recruiting

Phase 2

Safety, Tolerability, and Efficacy of AXA1125 in NASH With Fibrosis

Sponsor:

Axcella Health, Inc

Code:

NCT04880187

Conditions

Non Alcoholic Steatohepatitis (NASH)

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

AXA1125

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-16. This information was provided to ClinicalTrials.gov by Axcella Health, Inc on 2022-09-08.